GlassScriptPhysician profile
Lori L Clark
NPI 1972634897
$1,160.12
in general payments reported to CMS, 2019-2025
21 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $43.47 · 2021: $240 · 2022: $187 · 2023: $176 · 2024: $228 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $586.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $232.55 | 2019-2025 | Evenity, Prolia, Prolia |
| Inari Medical, INC. | $113.30 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $90.35 | 2021-2023 | Xarelto |
| Abbvie INC. | $88.08 | 2021-2023 | Vraylar |
| Bayer Healthcare Pharmaceuticals INC. | $84.93 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $68.42 | 2023-2025 | Rexulti, Jynarque |
| Pfizer INC. | $64.38 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $58.84 | 2021-2025 | Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.15 | 2020-2023 | Xifaxan |
| Merck Sharp & Dohme LLC | $48.20 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $44.62 | 2019-2022 | |
| Lundbeck LLC | $42.32 | 2023-2025 | Rexulti |
| Radius Health, INC. | $28.90 | 2019 | |
| Eisai INC. | $27.27 | 2020-2021 | |
| Glaxosmithkline, LLC. | $21.62 | 2025 | Arexvy, Shingrix |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $19.97 | 2021 | |
| Exact Sciences Corporation | $18.63 | 2024 | Cologuard Collection Kit |
| Stryker Corporation | $17.62 | 2025 | Ivas |
| Tactile Systems Technology INC | $16.47 | 2021 | |
| Seqirus USA INC | $13.00 | 2019 | |
| Endogastric Solutions, INC | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.